405 related articles for article (PubMed ID: 2129395)
21. Effects of mast cell growth factor on Ara-C mediated acute myeloid leukemia cell killing.
Tafuri A; De Felice L; Mascolo MG; Valentini T; Petrucci MT; Petti MC
Stem Cells; 1993 Jul; 11 Suppl 2():88-92. PubMed ID: 7691332
[TBL] [Abstract][Full Text] [Related]
22. Synergistic and antagonistic effects of recombinant human interleukin (IL) 3, IL-1 alpha, granulocyte and macrophage colony-stimulating factors (G-CSF and M-CSF) on the growth of GM-CSF-dependent leukemic cell lines.
Santoli D; Yang YC; Clark SC; Kreider BL; Caracciolo D; Rovera G
J Immunol; 1987 Nov; 139(10):3348-54. PubMed ID: 3500218
[TBL] [Abstract][Full Text] [Related]
23. Constitutive expression of leukemia inhibitory factor RNA by human bone marrow stromal cells and modulation by IL-1, TNF-alpha, and TGF-beta.
Wetzler M; Talpaz M; Lowe DG; Baiocchi G; Gutterman JU; Kurzrock R
Exp Hematol; 1991 Jun; 19(5):347-51. PubMed ID: 1709108
[TBL] [Abstract][Full Text] [Related]
24. Modulation of human melanoma cells by interleukin-4 and in combination with gamma-interferon or alpha-tumor necrosis factor.
Hoon DS; Banez M; Okun E; Morton DL; Irie RF
Cancer Res; 1991 Apr; 51(8):2002-8. PubMed ID: 1901239
[TBL] [Abstract][Full Text] [Related]
25. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation.
Murohashi I; Endho K; Nishida S; Yoshida S; Jinnai I; Bessho M; Hirashima K
Exp Hematol; 1995 Aug; 23(9):970-7. PubMed ID: 7543418
[TBL] [Abstract][Full Text] [Related]
26. The pleiotropic actions of leukemia inhibitory factor.
Gough NM; Williams RL
Cancer Cells; 1989 Nov; 1(3):77-80. PubMed ID: 2518284
[TBL] [Abstract][Full Text] [Related]
27. Participation of the cytokines interleukin 6, tumor necrosis factor-alpha, and interleukin 1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control.
Oster W; Cicco NA; Klein H; Hirano T; Kishimoto T; Lindemann A; Mertelsmann RH; Herrmann F
J Clin Invest; 1989 Aug; 84(2):451-7. PubMed ID: 2788173
[TBL] [Abstract][Full Text] [Related]
28. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of gamma-glutamyl transpeptidase activity at the surface of human myeloid cells is correlated with macrophage maturation and transforming growth factor beta production.
Bauvois B; Laouar A; Rouillard D; Wietzerbin J
Cell Growth Differ; 1995 Sep; 6(9):1163-70. PubMed ID: 8519693
[TBL] [Abstract][Full Text] [Related]
30. Human interleukin for DA cells (HILDA) does not affect the proliferation and differentiation of hematopoietic progenitor cells in human long-term bone marrow cultures.
Schaafsma MR; Falkenburg JH; Duinkerken N; Moreau JF; Soulillou JP; Willemze R; Fibbe WE
Exp Hematol; 1992 Jan; 20(1):6-10. PubMed ID: 1577095
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effects of cytokines on ovarian and endometrial carcinoma cells in vitro with special reference to induction of specific transcriptional regulators.
Seppänen M; Henttinen T; Lin L; Punnonen J; Grénman S; Punnonen R; Vihko KK
Oncol Res; 1998; 10(11-12):575-89. PubMed ID: 10367939
[TBL] [Abstract][Full Text] [Related]
32. The suppressive effects of recombinant human tumor necrosis factor-alpha on normal and malignant myelopoiesis: synergism with interferon-gamma.
Herrmann F; Bambach T; Bonifer R; Lindemann A; Riedel D; Oster W; Mertelsmann R
Int J Cell Cloning; 1988 Jul; 6(4):241-61. PubMed ID: 3138311
[TBL] [Abstract][Full Text] [Related]
33. Monocytic differentiation of a myelomonocytic leukemic cell (WEHI 3B JCS) is induced by tumour necrosis factor-alpha (TNF-alpha).
Mak NK; Fung MC; Leung KN; Hapel AJ
Cell Immunol; 1993 Aug; 150(1):1-14. PubMed ID: 7688266
[TBL] [Abstract][Full Text] [Related]
34. Regulation of hepatic endothelial cell and macrophage proliferation and nitric oxide production by GM-CSF, M-CSF, and IL-1 beta following acute endotoxemia.
Feder LS; Laskin DL
J Leukoc Biol; 1994 Apr; 55(4):507-13. PubMed ID: 8145021
[TBL] [Abstract][Full Text] [Related]
35. Cellular and cytokine dependent monocyte-mediated leukemic cell death: modulation by interferon-gamma and tumor necrosis factor-alpha.
van de Loosdrecht AA; Beelen RH; Ossenkoppele GJ; Broekhoven MG; Langenhuijsen MM
Exp Hematol; 1993 Mar; 21(3):461-8. PubMed ID: 8440344
[TBL] [Abstract][Full Text] [Related]
36. Combined effect of interferon-gamma and tumor necrosis factor-alpha causing suppression of leukemic blast progenitors in acute myeloblastic leukemia.
Nara N
Leuk Lymphoma; 1993 Jun; 10(3):201-7. PubMed ID: 7693101
[TBL] [Abstract][Full Text] [Related]
37. Transient expression of the IL-2 receptor alpha-chain in IL-6-induced myeloid cells is regulated by autocrine production of prostaglandin E2.
Ruhl S; Begley CG; Bickel M; Pluznik DH
Exp Hematol; 1992 Jun; 20(5):619-25. PubMed ID: 1587308
[TBL] [Abstract][Full Text] [Related]
38. Characterization of inhibitory activities secreted by THP-1 leukemia cells and regulation by interferon-gamma.
Gaffney EV
Growth Regul; 1991 Sep; 1(3):85-94. PubMed ID: 1842567
[TBL] [Abstract][Full Text] [Related]
39. Establishment and characterization of two novel cytokine-responsive acute myeloid and monocytic leukemia cell lines, MUTZ-2 and MUTZ-3.
Hu ZB; Ma W; Zaborski M; MacLeod R; Quentmeier H; Drexler HG
Leukemia; 1996 Jun; 10(6):1025-40. PubMed ID: 8667638
[TBL] [Abstract][Full Text] [Related]
40. Beneficial effects of post-transfusional hepatitis in acute myelogenous leukemia may be mediated by lipopolysaccharides, tumor necrosis factor alpha and interferon gamma.
Treon SP; Broitman SA
Leukemia; 1992 Oct; 6(10):1036-42. PubMed ID: 1405756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
